# Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

> **NCT00003805** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 859 (actual)

## Conditions studied

- Bone Marrow Suppression
- Fever, Sweats, and Hot Flashes
- Infection
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Unspecified Adult Solid Tumor, Protocol Specific
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** piperacillin sodium
- **DRUG:** piperacillin-tazobactam
- **DRUG:** tazobactam sodium
- **DRUG:** vancomycin

## Key facts

- **NCT ID:** NCT00003805
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** 2000-06
- **Final completion:** —
- **Target enrollment:** 859 (ACTUAL)
- **Last updated:** 2012-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003805, "Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT00003805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*